[Grade of malignancy and molecular alterations in breast carcinomas].
Asakawa
Hideki
H
Department of Surgery, National Defense Medical College.
Tsuda
Hitoshi
H
D001943:Breast Neoplasms / Q000145:classification / Q000235:genetics* / Q000473:pathology*; D015820:Cadherins / Q000235:genetics; D002869:Chromosome Aberrations; D066246:ErbB Receptors / Q000235:genetics; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009154:Mutation; D009367:Neoplasm Staging / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D017526:Receptor, IGF Type 1 / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D015820:Cadherins; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases; D017526:Receptor, IGF Type 1; D016159:Tumor Suppressor Protein p53